Toggle Dropdown
Announcements
Projects
News & Events
Welcome guest
Log in
Loading
Loading...
https://fortune.com/well/2022/09/24/new-covid-omicron-variants-subvariants-evade-monoclonal-antibodies-bebtelovimab-recombinants-convergent-evolution-sars-immune-evasion/
0
0
'The tools are getting picked off': An ever-mutating mix of COVID variants means fewer and less effective treatments this fall - Fortune
9/24/22 at 9:00am
Organization
Fortune
Author
Erin Prater
45 words
0
Comments
One up and coming variant renders society’s last universal COVID antibody drug powerless, experts say. Another variant isn’t far behind it.
Health
Arts & Entertainment
society
COVID
Fortune One
COVID antibody drug
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...